| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/15/2009 | CN101410397A Organic compounds |
| 04/15/2009 | CN101410396A Chromane derivatives |
| 04/15/2009 | CN101410390A Hydantoin compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410388A Compounds for the treatment of inflammatory disorders |
| 04/15/2009 | CN101410385A Benzothiazoles having histamine H3 receptor activity |
| 04/15/2009 | CN101410377A Process for preparing 6,7-dihydro-5h-imidazo[1,5-A]pyridin-8-one |
| 04/15/2009 | CN101410114A A3 adenosine receptor allosteric modulators |
| 04/15/2009 | CN101407516A Camptothecine derivative having anticancer activity |
| 04/15/2009 | CN101407515A Chinoline polycyclic compounds as CDK inhibitors |
| 04/15/2009 | CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
| 04/15/2009 | CN101407489A 2-alkyl acrylate compounds and uses thereof |
| 04/15/2009 | CN101406471A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/14/2009 | US7517994 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/14/2009 | US7517990 Method for deuteration of a heterocyclic ring |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517986 Such as N-(6-ethoxycarbonyl-3-cyano-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl)nicotinamide; cell-cycle specific inducers of apoptosis specific to cells with aberrant cell growth |
| 04/14/2009 | US7517904 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 04/14/2009 | US7517899 Phenylaminopropanol derivatives and methods of their use |
| 04/14/2009 | US7517887 Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/14/2009 | CA2468658C [1,2,4]-triazole bicyclic adenosine a2a receptor antagonists |
| 04/09/2009 | WO2009045753A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | WO2009045489A2 Process for the synthesis of cmhtp, a paliperidone intermediate |
| 04/09/2009 | WO2009044777A1 Oxazolidinone derivative having 7-membered hetero ring |
| 04/09/2009 | WO2009044413A2 Improved process for preparing paliperidone, novel polymorphic forms of the same and process thereof |
| 04/09/2009 | WO2009044147A1 Indolizine derivatives with crth2 receptor affinity for the treatment of inflammatory diseases |
| 04/09/2009 | WO2009044134A1 Indolizine derivatives with crth2 receptor affinity for the treatment of inflammatory diseases |
| 04/09/2009 | WO2009023253A3 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO |
| 04/09/2009 | WO2009007535A3 Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics |
| 04/09/2009 | WO2008155666A3 Heteroarylamide-substituted pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 04/09/2009 | WO2008151927A3 6-n-substituted benz imidazole derivatives as acid pump antagonists |
| 04/09/2009 | WO2008149163A3 Potassium ion channel modulators and uses thereof |
| 04/09/2009 | WO2008021342A3 Amorphous and crystalline forms of 9-hydroxy-risperidone ( paliperidone ) |
| 04/09/2009 | WO2007123732A3 Antifungal and antiparasitic indoloquinoline derivatives |
| 04/09/2009 | WO2007089336A3 Certain chemical entities, compositions and methods |
| 04/09/2009 | US20090093634 For therapy and prophylaxis of cardiovascular diseases, diabetes, diabetes- associated disorders, inflammatory diseases, immunological disorders, dermatological disorders, oncological disorders and central nervous system disorders |
| 04/09/2009 | US20090093516 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | US20090093515 Substituted pyrroline kinase inhibitors |
| 04/09/2009 | US20090093512 1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one derivatives which bind to neuronal nicotinic acetylcholine specific receptor sites and are useful in modulating cholinergic function and in the treatment of addictive disorders |
| 04/09/2009 | US20090093501 Heterocyclic antiviral compounds |
| 04/09/2009 | US20090093478 N-aroyl cyclic amines |
| 04/09/2009 | US20090093473 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 04/09/2009 | US20090093469 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/09/2009 | US20090093465 Therapeutic kinase modulators |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/09/2009 | US20090091252 Binaphthyl compound and organic light emitting element using the same |
| 04/09/2009 | US20090091240 Compound containing fused ring and organic electroluminescent element employing the same |
| 04/09/2009 | CA2701630A1 Quinolone analogs and methods related thereto |
| 04/09/2009 | CA2701355A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/08/2009 | EP2045252A2 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
| 04/08/2009 | EP2045243A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 04/08/2009 | EP2045242A1 Heterocyclic compounds having inhibitory activity against HIV integrase |
| 04/08/2009 | EP2044958A2 Pharmaceutical composition for treating arteriosclerosis |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044068A1 1-hydroxy naphthyridine compounds as anti-hiv agents |
| 04/08/2009 | EP2044065A2 Compounds and compositions as hedgehog pathway modulators |
| 04/08/2009 | EP2044061A2 Benzothiophene inhibitors of rho kinase |
| 04/08/2009 | EP2044051A1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 04/08/2009 | EP2044041A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions |
| 04/08/2009 | EP2044035A1 Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement |
| 04/08/2009 | EP2044032A2 Novel inhibitors of hepatitis c virus replication |
| 04/08/2009 | EP2044016A2 4-heteroaryl-substituted 1-aminocyclohexane-1-and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/08/2009 | EP2043655A2 Purine and deazapurine derivatives as pharmaceutical compounds |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists |
| 04/08/2009 | CN101405288A Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase |
| 04/08/2009 | CN101405282A Aurora kinase modulators and method of use |
| 04/08/2009 | CN101405281A Inhibitors of the interaction between MDM2 and P53 |
| 04/08/2009 | CN101405277A Dicarbonylic compounds with antibacterial activity |
| 04/08/2009 | CN101405267A Process for preparing l-halo-2,7-naphthyridinyl derivatives |
| 04/08/2009 | CN101402636A Propellane compounds, preparation method and application thereof |
| 04/08/2009 | CN101402635A Process for producing 5-chlorine-7-aza indole |
| 04/08/2009 | CN100475822C Synthesis method for producing ecteinascidin compound |
| 04/08/2009 | CN100475814C 7-azaindoles and use thereof as therapeutic agents |
| 04/08/2009 | CN100475813C 4-oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitor |
| 04/08/2009 | CN100475812C Pyrazolopyridines as cyclin dependent kinase inhibitors |
| 04/08/2009 | CN100475207C 1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 04/07/2009 | US7514583 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 04/07/2009 | US7514564 Substituted amine derivatives and methods of use |
| 04/07/2009 | US7514558 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary disease; asthma |
| 04/07/2009 | US7514451 1 -cyclopropyl-7- [3-cyclopropylaminomethyl-4-fluoro-1 -pyrrolidinyl]-6-fluoro -1 ,4-dihydro-8-methyl-4-oxo-3-quinolinecarboxylic acid; bactericide; against drug-resistant bacteria and against gram-positive bacteria, such as MRSA, PRSP and VRE |
| 04/07/2009 | US7514448 Azaindoles useful as inhibitors of rock and other protein kinases |
| 04/07/2009 | US7514430 Nitrogen compounds such as N-phenyl-N'-{(1R,2S)-2-[(2S)-2-benzyl-6-oxo-morpholin-4-yl-methyl]-cyclohexyl }-urea, used to control chemotactic cytokines, and administered for the prevention of asthma or allergies; inhibition of the migration of eosinophils |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/07/2009 | US7514418 silyl camptothecin derivatives for cancer and/or leukemia; cytotoxic; DNA-topoisomerase I inhibitors; antitumor agents; 7-trimethylsilyl-10-acetoxy camptothecin, 7-trimethylsilyl-11-fluoro camptothecin |
| 04/07/2009 | CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
| 04/07/2009 | CA2118239C 1h-imidazo{4,5-c}quinolin-4-amines as vaccine adjuvants |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041566A1 Preventive or remedy for posterior eye diseases containing quinazolinone derivative or quinoxaline derivative as the active ingredient |
| 04/02/2009 | WO2009041565A1 Quinazolinone derivative, and prophylactic or therapeutic agent for corneal/conjunctival disorder comprising quinazolinone derivative as active ingredient |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009040399A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2009039635A1 Methods of modulating neurotrophin-mediated activity |
| 04/02/2009 | WO2009019553A3 Imidazopyridinones |
| 04/02/2009 | US20090088573 Biologically active peptides and compositions, their use |
| 04/02/2009 | US20090088572 Method for preparing ladderanes |
| 04/02/2009 | US20090088570 Organic electroluminescent device |